Core Laboratories N.V.

Core Laboratories N.V.

CLB
Core Laboratories N.V.US flagNew York Stock Exchange
12.54
USD
+0.01
- -
578.05MMarket Cap
Core Laboratories N.V.
CLB
(New York Stock Exchange)

Recent

price

12.54

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
17.73
19.61
21.17
23.8
24.87
18.82
13.37
14.66
15.81
15.03
10.93
10.15
10.5
10.88
11.19
11.34
11.38
Revenue per Share
3.23
3.99
4.66
5.38
5.9
2.71
1.45
1.88
1.79
2.29
-2.19
0.43
0.42
0.78
0.67
0.64
0.53
Basic EPS, GAAP
4.59
4.41
5.08
6.53
6.93
5.14
2.98
2.8
2.5
2.01
1.29
0.78
0.53
0.53
1.2
0.8
0.62
Free Cash Flow per Basic Share
0.89
0.99
1.14
1.3
2.04
2.22
2.15
2.2
2.19
2.19
0.28
0.04
0.04
0.04
0.04
0.04
0.04
Dividend per Share
6.36
3.74
3.93
3.62
2.01
-0.69
3.43
3.28
3.54
4
1.6
3.38
3.95
4.8
5.27
5.77
5.94
Book Value per Share
2.78
0.14
0.22
-0.24
-2.01
-5.13
-0.85
-0.99
-1.71
-1.19
-0.82
1.05
1.66
2.53
3.01
3.32
3.49
Tangible Book Value per Share
45
46
46
45
44
42
44
44
44
44
45
46
47
47
47
46
46
Basic Weighted Avg Shares
795
908
981
1,074
1,085
798
590
648
701
668
487
470
490
510
524
527
519
Sales/Revenue/Turnover
28.28
27.53
29.88
31.03
32.03
23.53
14.75
17.07
16.82
15.49
12.13
8.5
8.44
11.02
9.5
9.59
7.92
Operating Margin (%)
23
23
23
25
27
27
27
25
23
23
21
19
17
16
15
15
15
Depreciation Expense
145
185
216
243
257
115
64
83
80
102
-98
20
19
37
31
30
24
Net Income, GAAP
30.48
22.69
24.91
24.96
23.01
22.7
14.31
18.39
24.17
- -
- -
44.01
34.37
10.16
30.39
33.78
32.89
Effective Tax Rate (%)
18.24
20.35
22.02
22.62
23.73
14.4
10.83
12.83
11.35
15.26
-20.04
4.19
3.97
7.19
5.99
5.63
4.69
Profit Margin (%)
70
143
156
168
170
118
82
107
128
110
76
98
109
135
119
109
113
Working Capital
9
223
234
267
354
431
216
227
290
370
316
238
211
205
169
153
153
LT Debt
292
182
188
169
94
-24
155
149
161
182
76
161
189
230
252
272
279
Total Equity
31.5
43.11
51.31
55.87
58.25
33.04
18.54
23.4
21.29
- -
- -
5.37
6.48
11.57
7.68
7.56
6.19
Return on Invested Capital (%)
33.09
45.14
53.59
58.12
59.84
29.08
18.96
24.59
21.63
- -
- -
5.99
6.53
11.3
8.95
8.28
7.06
Return on Capital (%)
50.95
79.03
120
140.53
205.25
36.03
31.21
56.13
52.74
60.95
-78.3
17.31
11.42
17.93
13.32
11.58
9.12
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
11
12
12
LT Borrowings
110
114
114
LT Finance Leases
42
41
39
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
46
46
Market Capitalization
739
773
535

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
215
214
214
Cash, Cash Equivalents & STI
23
23
23
Accounts Receivable, Net
114
108
109
Inventories
54
58
58
Total Current Liabilities
106
105
101
Payables & Accruals
72
71
67
ST Debt
11
12
12
Deferred Revenue
6
5
5

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-62.7%
33.94%
7.88%
Free Cash Flow
-8.66%
4.91%
-34.33%
Net Income, GAAP
-23.9%
-10.59%
-5.51%
Sales/Revenue/Turnover
-3.18%
1.6%
0.51%
Total Cash Common Dividend
-16.71%
-16.67%
-0.37%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130
131
134
129
524
2025
124
130
135
138
527
2026
122
125
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.19
0.25
0.16
0.67
2025
- -
0.23
0.31
0.11
0.64
2026
-0.02
0.13
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
0.01
0.04
2025
0.01
0.01
0.01
0.01
0.04
2026
0.01
0.01
- -
- -
- -
Business
Core Laboratories N.V. (NYSE: CLB) provides proprietary and patented reservoir description, production enhancement, and reservoir management services and products to the oil and gas industry worldwide. The company offers core analysis including basic rock properties, special core analysis, digital rock characterization, and non-invasive technologies such as NITRO SM for rapid Fit-For-Reservoir TM core and fluid data; reservoir fluid characterization and PVT analysis; production enhancement solutions encompassing proppant crush testing with Complete Crush TM, hydraulic fracturing diagnostics, production logging, well spacing diagnostics using tracers, and enhanced oil recovery studies; petroleum products testing and crude oil assays; carbon capture and storage subsurface characterization; laboratory instruments, pumps, and accessories; as well as reservoir modeling, simulation, and field development planning. Core Laboratories operates through three segments—Reservoir Description, Production Enhancement, and Reservoir Management—serving major, national, and independent oil companies across more than 50 countries on six continents with over 70 offices and four advanced technology centers. Founded in 1936 with roots in Dallas, Texas, and headquartered in Houston, Texas, the company, incorporated as a Netherlands limited liability company, maintains approximately 3,200 employees. In 2025, Core Laboratories completed the acquisition of Brazil-based Solintec, an integrated geological services provider, for an initial $2.3 million plus potential earnout of up to $3.7 million to expand in-country capabilities for pre-salt offshore and onshore projects along the South Atlantic Margin.

Company News

  • 3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges

  • BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB

  • Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

  • Advisors Capital Management LLC Makes New $2.77 Million Investment in Core Laboratories Inc. $CLB

  • John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value

  • DTI or CLB: Which Is the Better Value Stock Right Now?

  • Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

  • Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

  • Core Laboratories Q2 Earnings Call Highlights

  • Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

  • Core Laboratories (CLB) Q2 Earnings Surpass Estimates

  • CORE LAB REPORTS SECOND QUARTER 2026 RESULTS

  • Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity

  • What's in Store for Core Laboratories Stock in Q2 Earnings?

  • Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline

  • Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?

  • CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

  • Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?

  • Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics

  • Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?